Navigation Links
Professional Combi Retinoscope

ProductsProfessional Combi Retinoscope
Company Keeler Instruments Inc.
Item Professional Combi Retinoscope
Features The brightest retinoscope on the market, guarantees you more than enough light to refract even the most difficult eyes. Dual Purpose - either streak or spot with a quick change of the halogen bulb. Neutralization Check - unique double check facility to cross check neutralization. Magnetic Sleeve - 360o access to a single control for both rotation and convergence.
Description Keeler ophthalmoscopes are individually adjusted for perfect focus where it's needed - in the eye, not on paper. This, along with Keeler's wide angle light beam and infinity focus, ensures that whatever the patient's pupil size, you will see the clearest and largest field of view. Lithium-ion technology provides a longer life battery and fast charge capability. With curved surfaces and subtle patient side marking, each ophthalmoscope has been designed to fit snugly into the orbital bone.
Info Keeler Instruments Inc.
Customer Service: (800) 523-5620
Web site: http://www.keelerusa.com

Related medicine products :

1. Keeler Professional Combi Retinoscope
2. Hgb Pro Professional Hemoglobin Testing System
3. Winx Pro Practice Management Software for Eyecare Professionals
4. Vibratome Professional Package, 110 Volt, 50/60Hz
5. Vibratome Professional Package, 230 V. 50/60Hz
6. OneTouch Flexx Professional Blood Glucose Monitoring System
7. Professional Ophthalmoscope
8. Professional Direct Ophthalmoscope
9. HandEchart Professional
10. PCA Professional™ TCA Peels
11. Professional Assessment Set
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products:
(Date:9/8/2008)...pists, occupational therapists and other rehabilit...ent increases through 2016. , ...nificant milestones through the help and dedicatio...e http://www.nraf-rehabnet.org/ [National Rehabi...he 2008 National Rehabilitation Awareness Celebrat...
(Date:9/7/2008)...a growing obesity epidemic in the United States, r...al Center have new study results that indicate tha... where that fat is located when assessing risk for... "We are facing an obesity epidemic, which obvious...ardiovascular disease, etc.," said Jingzhong Ding,...
(Date:9/5/2008)...-USNewswire/ -- Children and,families across Penns...ervices to protect their health and well-being thr...nced today by the Department of Public Welfare., ...lies, the department,began developing the nation,s...tiative, ICSP, in 2004. Through this initiative, c...
(Date:9/5/2008)...hows Public Reluctant to Evacuate, Without Their C... Confirm Survey Result...by the American Humane,Association found that 47 p... if it meant leaving without their family pet. Wit...ds the U.S. coast, residents and,officials should ...
Breaking Medicine News(10 mins):Health News:U.S. Demand for Rehabilitation Professionals Grows 2Health News:U.S. Demand for Rehabilitation Professionals Grows 3Health News:'Healthy' individuals may be at risk for heart disease 2Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4
...is threatening to cause a major upheaval to the Na...he spread, according to the Coordinating Minister/...n’s Economic Minister, equally concerned, has expr... a consequent fall back in the Nation’s Economic c...
...icine, one should reevaluate new medicines and tre...D., Dr. Berry, professor and chair of the Depart...he University of Texas M. D. Anderson Cancer Cente...rials are designed and conducted in the U.S. He th...
...a Pechman ruled in Seattle that the Virginia Mason...shots or give up their jobs.// This ruling came af...e hospital had asked the 600-strong nursing staff ... duty" measure. In August last year, a labor arbit...
...a massive stroke on Jan 4 underwent a surgery sinc...The PM is in a critical situation and is 77 years ...ital in Jerusalem where he has already had seven h... and stop bleeding in his brain. As a statement by...
Other Medicine News:Health News:New Generation Clinical Trials Could Save Time And Money, Improve Patient Care 2
(Date:9/4/2008)...swire/ -- Cytopia Limited (ASX:,CYT) today announc...b/II,study of CYT997, the company,s novel vascular...aggressive form of brain cancer known as glioblast...the first Phase II efficacy study in highly,vascul...e second in its,suite of Phase II studies designed...
(Date:9/4/2008)...nd Presented at ESC Congress-, PHILADELPHIA, Sept...al,study, the GISSI Heart Failure (GISSI-HF) study...ers reduced all cause mortality and hospital,admis...chronic heart,failure. These findings are publishe...d were presented at the European Cardiovascular So...
(Date:9/4/2008)...Newswire/ -- Axentis Pharma AG has,initiated a cli...erability,of a new therapeutic formulation for the... fibrosis patients. The new formulation allows an,...ctly to the site of,infection. The forthcoming tri...doses of the new drug. Initial results are expecte...
(Date:9/4/2008)... with Two Abstracts Accepted for Presentation,... BRIDGEWATER, N.J., Sept. 4 /- Aeger...cal company focused on the treatment of,cardiovasc...pointment of,Peter L. Garrambone, Jr. to the Compa...er includes more than 50 pharmaceutical,transactio...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2ClearWay Minnesota 28SM 29 Board Approves 242 8 Million for Research Grants 6564 1ClearWay Minnesota 28SM 29 Board Approves 242 8 Million for Research Grants 6564 2ClearWay Minnesota 28SM 29 Board Approves 242 8 Million for Research Grants 6564 3First study of Australias high cost of pain reveals 2434 billion price tag 6562 1First study of Australias high cost of pain reveals 2434 billion price tag 6562 2MIT 3A Micro livers could aid drug screening 1258 1MIT 3A Micro livers could aid drug screening 1258 2MIT 3A Micro livers could aid drug screening 1258 3Mini Strokes 3A Major Health Threats 6558 1Mini Strokes 3A Major Health Threats 6558 2Mini Strokes 3A Major Health Threats 6558 3
...0-Patient Lung Cancer Diversity Study, CHICAGO, Ju...how,lung cancer is the leading cause of cancer dea...ected to be diagnosed,and 16,700 deaths expected t...he leading cause of cancer death in Hispanic men a...panic women.(ii),Researchers at Eli Lilly and Comp...
...of pivotal trial confirms that more patients,are a...ne 4, 2007-A follow-up analysis tracking,the outco...oma,(NHL) who were treated with the innovative can...ago has revealed exciting results,(1). , This anal...hown,that over half (53%) of the patients treated ...
Other Medicine Technology:Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 2Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 3Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 4Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 5Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 7Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 8Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 9Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 10Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 11MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 2MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 3MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 4